leadf
logo-loader
viewe-Therapeutics PLC

e-Therapeutics PLC's Ali Mortazavi welcomes new fibrosis collaboration with Galapagos

e-therapeutics PLC's (LON: ETX.L) chairman Ali Mortazavi speaks to Proactive London's Andrew Scott after announcing they're to join forces with Belgian life sciences giant Galapagos to uncover a new means of treating idiopathic pulmonary fibrosis, a serious lung disease with a poor prognosis.

The work will focus on approaches to modulate one specific mechanism involved in IPF and other fibrotic conditions.

Quick facts: e-Therapeutics PLC

Price: 16 GBX

AIM:ETX
Market: AIM
Market Cap: £67.05 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of e-Therapeutics PLC named herein, including the promotion by the Company of e-Therapeutics PLC in any Content on the Site, the Company receives...

FOR OUR FULL DISCLAIMER CLICK HERE

Morning Report: FTSE 100 makes early rally as airline losses set to total...

Headlines from the Proactive UK newsroom. The FTSE 100 rallied early on after two days of losses with travel groups leading the way. The blue-chip index was up 30 points at 6,366. Airline losses will total around US$84bn this year according to the International Air Transport Association....

on 10/6/20

2 min read